Roche (RHHBY) News Today $45.73 +0.41 (+0.90%) As of 11:01 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock RHHBY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Roche (OTCMKTS:RHHBY) Sets New 1-Year High - Should You Buy?October 8 at 11:25 AM | marketbeat.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)October 8 at 11:22 AM | globenewswire.com89bio Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNBOctober 6 at 5:10 PM | businesswire.comSA Asks: What's the most attractive Big Pharma stock right now?October 6 at 2:33 AM | msn.comRoche receives CE Mark for AI-based Kidney Klinrisk Algorithm(1) and launches new comprehensive chronic kidney disease (CKD) algorithm panelOctober 6 at 2:00 AM | globenewswire.comOLD National Bancorp IN Acquires 7,326 Shares of Roche Holding AG $RHHBYOctober 5, 2025 | marketbeat.comBoston Common Asset Management LLC Acquires 36,101 Shares of Roche Holding AG $RHHBYOctober 5, 2025 | marketbeat.comRoche (OTCMKTS:RHHBY) Upgraded at Hsbc Global ResOctober 5, 2025 | americanbankingnews.comRoche (OTCMKTS:RHHBY) Stock Rating Upgraded by Hsbc Global ResOctober 3, 2025 | marketbeat.comFDA approves Roche’s Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancerOctober 3, 2025 | uk.finance.yahoo.comFDA approves Roche's Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancerOctober 3, 2025 | globenewswire.comChange in the Roche Board of DirectorsOctober 3, 2025 | globenewswire.comFDA Approves Genentech's Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung CancerOctober 2, 2025 | businesswire.comRoche upgraded to Buy from Hold at HSBC (yesterday)October 2, 2025 | msn.comRoche (OTCMKTS:RHHBY) Reaches New 1-Year High - Here's What HappenedOctober 2, 2025 | marketbeat.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) & Roche (OTCMKTS:RHHBY) Critical ComparisonOctober 2, 2025 | americanbankingnews.comRoche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cashOctober 1, 2025 | globenewswire.comRoche (OTCMKTS:RHHBY) Shares Gap Up - Should You Buy?October 1, 2025 | marketbeat.comRoche Holding AG - Depositary Receipt (RHHBY) Price Target Increased by 13.65% to 96.48September 30, 2025 | msn.comData show Roche's sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacksSeptember 30, 2025 | globenewswire.comRiverbridge Partners LLC Has $376,000 Stock Position in Roche Holding AG $RHHBYSeptember 26, 2025 | marketbeat.comRoche points to U.S. plans after Trump pharma tariff announcementSeptember 26, 2025 | reuters.comGenentech presents new Ocrevus, fenebrutinib data at ECTRIMS congressSeptember 25, 2025 | msn.comRoche targets becoming top 3 obesity player as experimental drug enters late-stage trialSeptember 25, 2025 | cnbc.comRoche Holding AG (RHHBY) Discusses On Pharma Day 2025 (Transcript)September 24, 2025 | seekingalpha.comGenentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025September 24, 2025 | businesswire.comRoche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025September 24, 2025 | globenewswire.comRoche Holding AG - Special CallSeptember 22, 2025 | seekingalpha.comRoche Targets Top Spot In Weight Loss Drug MarketSeptember 22, 2025 | benzinga.comRoche CEO, pharma execs to meet with Swiss government over US tariffsSeptember 22, 2025 | reuters.comRoche says breast cancer drug combo including giredestrant met main goals in late stage trialSeptember 22, 2025 | msn.comRoche shares rise as firm advances experimental obesity drug to late-stage trialSeptember 22, 2025 | reuters.comRoche's Drug Candidate Meets Main Goals in Late-Stage Breast Cancer StudySeptember 22, 2025 | wsj.comPositive Phase III Results Show Genentech's Giredestrant Significantly Improved Progression-Free Survival in ER-positive Advanced Breast CancerSeptember 22, 2025 | businesswire.comPositive phase III results show Roche's giredestrant significantly improved progression-free survival in ER-positive advanced breast cancerSeptember 22, 2025 | globenewswire.com89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNBSeptember 19, 2025 | businesswire.comCHMP recommends EU approval of Roche's subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphomaSeptember 19, 2025 | globenewswire.comRoche's 89bio Buyout: Building A Combo-Ready Metabolic Franchise Beyond GLP-1 WarsSeptember 19, 2025 | seekingalpha.comRoche Expands Cardiometabolic Pipeline With 89bio AcquisitionSeptember 19, 2025 | seekingalpha.comRoche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic PushSeptember 18, 2025 | benzinga.comRoche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total testSeptember 18, 2025 | prnewswire.comRoche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio BuyoutSeptember 18, 2025 | investors.comStock Movers: NVDA, Roche, PLTRSeptember 18, 2025 | bloomberg.comRoche to acquire 89bio in deal worth up to $3.5 billionSeptember 18, 2025 | msn.comRoche to Buy 89bio for Up to $3.5 BillionSeptember 18, 2025 | wsj.comRoche to acquire liver drug developer 89bio for up to $3.5 billionSeptember 18, 2025 | reuters.comRoche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASHSeptember 18, 2025 | globenewswire.comRoche receives CE Mark for Accu-Check SmartGuide CGM solutionSeptember 16, 2025 | msn.comRoche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experienceSeptember 16, 2025 | prnewswire.comHenlius Biotech in talks with J&J, Roche on cancer drug: reportSeptember 16, 2025 | msn.com Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.470.63▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼158▲RHHBY Articles Average Week Get the Latest News and Ratings for RHHBY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Roche and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies China Construction Bank News Airbus News EssilorLuxottica News Iberdrola News Nintendo News BNP Paribas News Atlas Copco News Vinci News Japan Tob News Bayerische Motoren Werke News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
